Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Robert H. Vondeheide
Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy
Applied Immunohistochemistry and Molecular Morphology
Forensic Medicine
Pathology
Medical Laboratory Technology
Histology
Tissue Factor as a New Target for CAR-NK Cell Immunotherapy of Triple-Negative Breast Cancer
Scientific Reports
Multidisciplinary
Role of Immunotherapy in Triple-Negative Breast Cancer
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer
Clinical Breast Cancer
Cancer Research
Oncology
Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
Scientific Reports
Multidisciplinary
ICAM-1 as a Molecular Target for Triple Negative Breast Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The Clinical Promise of Immunotherapy in Triple-Negative Breast Cancer
Cancer Management and Research
Oncology
Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer
Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes